Trademark Search in Canada

ORPHACARE & DESIGN

View On IC.GC.CA

APPROVED

on 1 May 2025

Last Applicant/ Owned by

OrphaCare GmbH

Leopold- Ungar- Platz 21190 Vienna,

Serial Number

2094867 filed on 25^th Mar 2021

Correspondent Address

BORDEN LADNER GERVAIS LLP

World Exchange Plaza100 Queen Street, Suite 1300Ottawa

ONTARIO

K1P1J9

ORPHACARE & DESIGN

Trademark usage description

pharmaceutical preparations for the treatment of hematological, cardiovascular, and pulmonary diseases and disorders; pharmaceutical preparations for Read More

Vienna Information

26 . 1 . 2

EllipsesEllipses

26 . 1 . 3

One circle or ellipseUn cercle ou une ellipse

26 . 1 . 18

Circles or ellipses containing one or more lettersCercles ou ellipses contenant une ou plusieurs lettres

26 . 1 . 19

Circles or ellipses with inscriptions projecting beyond the circumferenceCercles ou ellipses avec inscriptions débordant la circonférence

26 . 1 . 26

Circles or ellipses with cutout areasCercles ou ellipses avec des zones découpées

26 . 2 . 1

Segments of circles or ellipses (except 26.2.7)Segments de cercle ou d'ellipse (excepté 26.2.7)

29 . 1 . 1

Red, pink, orangeRouge, rose, orangé

29 . 1 . 6

White, grey, silverBlanc, gris, argent

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of hematological, cardiovascular, and pulmonary diseases and disorders; Pharmaceutical preparations for the treatment of age related diseases, namely, angina, arrhythmia, atherosclerosis, cardiomyopathy, congestive heart failure, coronary artery disease (CAD), carotid artery disease, endocarditis, coronary thrombosis, carotid thrombosis, myocardial infarction (MI), high blood pressure/hypertension, aortic aneurysm, brain aneurysm, cardiac fibrosis, cardiac diastolic dysfunction, hypercholesterolemia/hyperlipidemia, mitral valve prolapse, peripheral vascular disease, peripheral artery disease (PAD), cardiac stress resistance, stroke, Parkinson's disease, Alzheimer's disease, dementia, amyotrophic lateral sclerosis (ALS), bulbar palsy, pseudobulbar palsy, primary lateral sclerosis, motor neuron dysfunction (MND), mild cognitive impairment (MCI), Huntington's disease, ocular diseases, macular degeneration (wet and dry), glaucoma, vision loss, presbyopia, cataracts, progressive muscular atrophy, lower motor neuron disease, spinal muscular atrophy (SMA), Werdnig-Hoffman Disease (SMA1), SMA2, Kugelberg-Welander Disease (SM3), Kennedy's disease, post-polio syndrome, hereditary spastic paraplegia, age-related memory decline, and depression and mood disorders, musculoskeletal diseases, osteoarthritis, osteoporosis, sarcopenia, lupus, interstitial cystitis, scleroderma, alopecia, oral mucositis, rheumatoid arthritis, inflammatory bowel disease, kyphosis, herniated intervertebral disc, ulcerative colitis, Crohn's disease, ulcerative asthma, renal fibrosis including post-transplant renal fibrosis, liver fibrosis, pancreatic fibrosis, cardiac fibrosis, skin wound healing including diabetes related wound healing, and oral submucosa fibrosis, irritable bowel syndrome (IBS) and inflammatory bowel diseases, namely ulcerative colitis and Crohn's disease, Inflammatory bowel disease (IBD), psoriasis, eczema, rhytides, pruritus, dysesthesia, papulosquamous disorders, erythroderma, lichen planus, lichenoid dermatosis, atopic dermatitis, eczematous eruptions, eosinophilic dermatosis, rashes, photosensitivity and photoaging related diseases and disorders, reactive neutrophilic dermatosis, pemphigus, pemphigoid, immunobullous dermatosis, fibrohistocytic proliferations of skin, skin nevi, urticaria, hyperpigmentation, cutaneous lymphomas, psoriasis, and cutaneous lupus, type I and type II diabetes mellitus, diabetic ulcers and obesity, macular degeneration, dry (non-neovascular) or wet (neovascular) macular degeneration, idiopathic pulmonary fibrosis (TPF), chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis, bronchiectasis, emphysema, age-related loss of pulmonary function, and age-associated sleep apnea; Pharmaceutical preparations for the treatment of neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy, myasthenia gravis and brain injury, spinal cord injury, seizure disorders; Pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, psychoses, schizophrenia and bipolar disorders; Pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis, anemia, obesity, hyperlipidemia, insulin resistance, hypoglycaemia, osteoarthritis, muscular dystrophy, bulimia nervosa, anorexia, hypothyroidism, arthritis and metabolic syndrome; Anaesthetics for surgical use; general anaesthetics; inhalant anaesthetics; local anaesthetics; topical anaesthetics; pharmaceutical preparations for maintaining normal blood pressure and heart function; antispasmodics; analgesics; anticonvulsants; medicinal preparations for the treatment of hematological, cardiovascular, and pulmonary diseases and disorders; medicinal preparations for the treatment of age related diseases, namely, angina, arrhythmia, atherosclerosis, cardiomyopathy, congestive heart failure, coronary artery disease (CAD), carotid artery disease, endocarditis, coronary thrombosis, carotid thrombosis, myocardial infarction (MI), high blood pressure/hypertension, aortic aneurysm, brain aneurysm, cardiac fibrosis, cardiac diastolic dysfunction, hypercholesterolemia/hyperlipidemia, mitral valve prolapse, peripheral vascular disease, peripheral artery disease (PAD), cardiac stress resistance, stroke, Parkinson's disease, Alzheimer's disease, dementia, amyotrophic lateral sclerosis (ALS), bulbar palsy, pseudobulbar palsy, primary lateral sclerosis, motor neuron dysfunction (MND), mild cognitive impairment (MCI), Huntington's disease, ocular diseases, macular degeneration (wet and dry), glaucoma, vision loss, presbyopia, cataracts, progressive muscular atrophy, lower motor neuron disease, spinal muscular atrophy (SMA), Werdnig-Hoffman Disease (SMA1), SMA2, Kugelberg-Welander Disease (SM3), Kennedy's disease, post-polio syndrome, hereditary spastic paraplegia, age-related memory decline, and depression and mood disorders, musculoskeletal diseases, osteoarthritis, osteoporosis, sarcopenia, lupus, interstitial cystitis, scleroderma, alopecia, oral mucositis, rheumatoid arthritis, inflammatory bowel disease, kyphosis, herniated intervertebral disc, ulcerative colitis, Crohn's disease, ulcerative asthma, renal fibrosis including post-transplant renal fibrosis, liver fibrosis, pancreatic fibrosis, cardiac fibrosis, skin wound healing including diabetes related wound healing, and oral submucosa fibrosis, irritable bowel syndrome (IBS) and inflammatory bowel diseases, namely ulcerative colitis and Crohn's disease; Inflammatory bowel disease (IBD), psoriasis, eczema, rhytides, pruritus, dysesthesia, papulosquamous disorders, erythroderma, lichen planus, lichenoid dermatosis, atopic dermatitis, eczematous eruptions, eosinophilic dermatosis, rashes, photosensitivity and photoaging related diseases and disorders, reactive neutrophilic dermatosis, pemphigus, pemphigoid, immunobullous dermatosis, fibrohistocytic proliferations of skin, skin nevi, urticaria, hyperpigmentation, cutaneous lymphomas, psoriasis, and cutaneous lupus, type I and type II diabetes mellitus, diabetic ulcers and obesity, macular degeneration, dry (non-neovascular) or wet (neovascular) macular degeneration, idiopathic pulmonary fibrosis (TPF), chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis, bronchiectasis, emphysema, age-related loss of pulmonary function, and age-associated sleep apnea; medicinal preparations for the treatment of neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy, myasthenia gravis and brain injury, spinal cord injury, seizure disorders; medicinal preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, psychoses, schizophrenia and bipolar disorders; medicinal preparations for the treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis, anemia, obesity, hyperlipidemia, insulin resistance, hypoglycaemia, osteoarthritis, muscular dystrophy, bulimia nervosa, anorexia, hypothyroidism, arthritis and metabolic syndrome; diuretics; medicinal preparations for maintaining normal blood pressure and heart function.

Classification kind code

Class [010]
Medical apparatus and devices for diagnostic and therapeutic use, namely drug delivery agents in the form of external and implantable micropumps for subcutaneous, intravenous and intrathecal use that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; implantable drug delivery pumps

Classification kind code

Class [035]
Trading transactions, namely, buying and negotiating services for the purchase of pharmaceuticals, natural remedies, medical preparations, medical apparatus and devices for others; Trading transactions, namely, buying and selling pharmaceuticals, natural remedies, medical preparations, medical apparatus and devices.

Classification kind code

Class [039]
Distribution of pharmaceuticals, natural remedies and medical preparations; Distribution of medical apparatus and devices.

Classification kind code

Class [044]
Advisory services relating to pharmaceuticals, medical preparations, medical apparatus and devices in the intensive care and emergency medicine, anesthesia, hemato-oncology, cardiology, pulmonology, neurology, metabolic disorders, and psychiatry, intended to patients.

Classification kind code

Mark Details

Serial Number

2094867

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 26 on 1^st May 2025	Approved
Submitted for opposition 27 on 1^st May 2025	Approval Notice Sent
Submitted for opposition 22 on 16^th Oct 2024	Search Recorded
Submitted for opposition 20 on 16^th Oct 2024	Examiner's First Report
Submitted for opposition 135 on 31^st May 2022	Amendment to Application
Submitted for opposition 287 on 2^th May 2022	Pre-Assessment Letter Sent
Submitted for opposition 30 on 25^th Mar 2021	Filed
Submitted for opposition 1 on 25^th Mar 2021	Created
Submitted for opposition 31 on 25^th Mar 2021	Formalized

ORPHACARE & DESIGN

Classification Information

Classification kind code

Classification kind code

Classification kind code

Class [039]Distribution of pharmaceuticals, natural remedies and medical preparations; Distribution of medical apparatus and devices.

Classification kind code

Class [044]Advisory services relating to pharmaceuticals, medical preparations, medical apparatus and devices in the intensive care and emergency medicine, anesthesia, hemato-oncology, cardiology, pulmonology, neurology, metabolic disorders, and psychiatry, intended to patients.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [039]
Distribution of pharmaceuticals, natural remedies and medical preparations; Distribution of medical apparatus and devices.

Class [044]
Advisory services relating to pharmaceuticals, medical preparations, medical apparatus and devices in the intensive care and emergency medicine, anesthesia, hemato-oncology, cardiology, pulmonology, neurology, metabolic disorders, and psychiatry, intended to patients.